The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cholangitis


High impact information on Cholangitis


Chemical compound and disease context of Cholangitis


Biological context of Cholangitis


Anatomical context of Cholangitis


Gene context of Cholangitis


Analytical, diagnostic and therapeutic context of Cholangitis


  1. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Colombato, L.A., Alvarez, F., Côté, J., Huet, P.M. Gastroenterology (1994) [Pubmed]
  2. Liver transplantation across ABO blood group barriers. Gugenheim, J., Samuel, D., Reynes, M., Bismuth, H. Lancet (1990) [Pubmed]
  3. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Tsuneyama, K., Van de Water, J., Leung, P.S., Cha, S., Nakanuma, Y., Kaplan, M., De Lellis, R., Coppel, R., Ansari, A., Gershwin, M.E. Hepatology (1995) [Pubmed]
  4. Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bromodeoxyuridine infusion in dogs. Wollner, I.S., Knutsen, C.A., Ullrich, K.A., Chrisp, C.E., Juni, J.E., Andrews, J.C., Tuscan, M.J., Stetson, P.L., Ensminger, W.D. Cancer Res. (1987) [Pubmed]
  5. Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice. Stephens, J., Cosyns, M., Jones, M., Hayward, A. Hepatology (1999) [Pubmed]
  6. Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Van Nieuwkerk, C.M., Elferink, R.P., Groen, A.K., Ottenhoff, R., Tytgat, G.N., Dingemans, K.P., Van Den Bergh Weerman, M.A., Offerhaus, G.J. Gastroenterology (1996) [Pubmed]
  7. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gordon, S.C., Quattrociocchi-Longe, T.M., Khan, B.A., Kodali, V.P., Chen, J., Silverman, A.L., Kiechle, F.L. Gastroenterology (1995) [Pubmed]
  8. Ciprofloxacin for cholangitis. Lonka, L., Pedersen, R.S. Lancet (1987) [Pubmed]
  9. Hydralazine-induced cholangitis. Myers, J.L., Augur, N.A. Gastroenterology (1984) [Pubmed]
  10. Acute cholangitis after allopurinol treatment. Korting, H.C., Lesch, R. Lancet (1978) [Pubmed]
  11. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. van den Hazel, S.J., Speelman, P., Dankert, J., Huibregtse, K., Tytgat, G.N., van Leeuwen, D.J. Ann. Intern. Med. (1996) [Pubmed]
  12. 16,16-dimethyl-PGE2 protection against alpha-naphthylisothiocyanate-induced experimental cholangitis in the rat. Ruwart, M.J., Rush, B.D., Friedle, N.M., Stachura, J., Tarnawski, A. Hepatology (1984) [Pubmed]
  13. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Gerecht, W.B., Henry, N.K., Hoffman, W.W., Muller, S.M., LaRusso, N.F., Rosenblatt, J.E., Wilson, W.R. Arch. Intern. Med. (1989) [Pubmed]
  14. Successful treatment of AIDS-related cryptosporidial sclerosing cholangitis. Hamour, A.A., Bonnington, A., Hawthorne, B., Wilkins, E.G. AIDS (1993) [Pubmed]
  15. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease. Klump, B., Hsieh, C.J., Dette, S., Holzmann, K., Kiebetalich, R., Jung, M., Sinn, U., Ortner, M., Porschen, R., Gregor, M. Clin. Cancer Res. (2003) [Pubmed]
  16. Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation. Masuda, S., Goto, M., Kiuchi, T., Uemoto, S., Kodawara, T., Saito, H., Tanaka, K., Inui, K. Liver Transpl. (2003) [Pubmed]
  17. Surgical treatment for congenital biliary dilatation, with or without intrahepatic bile duct dilatation. Hara, H., Morita, S., Ishibashi, T., Sako, S., Otani, M., Tanigawa, N. Hepatogastroenterology (2001) [Pubmed]
  18. Autoimmune hepatitis in primary Sjogren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren's syndrome. Matsumoto, T., Morizane, T., Aoki, Y., Yamasaki, S., Nakajima, M., Enomoto, N., Kobayashi, S., Hashimoto, H. Pathol. Int. (2005) [Pubmed]
  19. Development and characterization of a rodent model of immune-mediated cholangitis. Ueno, Y., Phillips, J.O., Ludwig, J., Lichtman, S.N., LaRusso, N.F. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  20. Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis. Tjandra, K., Sharkey, K.A., Swain, M.G. Hepatology (2000) [Pubmed]
  21. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Yeaman, S.J., Kirby, J.A., Jones, D.E. Immunol. Rev. (2000) [Pubmed]
  22. Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history. Sylvestre, P.B., Batts, K.P., Burgart, L.J., Poterucha, J.J., Wiesner, R.H. Liver Transpl. (2003) [Pubmed]
  23. Intraoperative fiberoptic choledochoscopy for malignant biliary tract obstruction. Chen, M.F., Jan, Y.Y., Wang, C.S., Jeng, L.B., Hwang, T.L. Gastrointest. Endosc. (1989) [Pubmed]
  24. Celiac disease in autoimmune cholestatic liver disorders. Volta, U., Rodrigo, L., Granito, A., Petrolini, N., Muratori, P., Muratori, L., Linares, A., Veronesi, L., Fuentes, D., Zauli, D., Bianchi, F.B. Am. J. Gastroenterol. (2002) [Pubmed]
  25. Biliary epithelial cell antibodies induce expression of toll-like receptors 2 and 3: a mechanism for post-liver transplantation cholangitis? Ge, X., Uzunel, M., Ericzon, B.G., Sumitran-Holgersson, S. Liver Transpl. (2005) [Pubmed]
  26. Requirement for TNF-Tnfrsf1 signalling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum. Ponnuraj, E.M., Hayward, A.R. Clin. Exp. Immunol. (2002) [Pubmed]
  27. Role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 during nonsuppurative destructive cholangitis in a mouse graft-versus-host disease model. Howell, C.D., Li, J., Chen, W. Hepatology (1999) [Pubmed]
  28. Regulation of organic anion transporters in a new rat model of acute and chronic cholangitis resembling human primary sclerosing cholangitis. Geier, A., Dietrich, C.G., Lammert, F., Orth, T., Mayet, W.J., Matern, S., Gartung, C. J. Hepatol. (2002) [Pubmed]
  29. A randomised controlled trial of endoscopic sphincterotomy in acute cholangitis without common bile duct stones. Hui, C.K., Lai, K.C., Wong, W.M., Yuen, M.F., Lam, S.K., Lai, C.L. Gut (2002) [Pubmed]
  30. Long term transhepatic intubation for hilar hepatic duct strictures. Cameron, J.L., Skinner, D.B., Zuidema, G.D. Ann. Surg. (1976) [Pubmed]
  31. L-arginine reduces liver and biliary tract damage after liver transplantation from non-heart-beating donor pigs. Valero, R., García-Valdecasas, J.C., Net, M., Beltran, J., Ordi, J., González, F.X., López-Boado, M.A., Almenara, R., Taurá, P., Elena, M., Capdevila, L., Manyalich, M., Visa, J. Transplantation (2000) [Pubmed]
  32. Prevalence of autoimmune liver disease in Alaska Natives. Hurlburt, K.J., McMahon, B.J., Deubner, H., Hsu-Trawinski, B., Williams, J.L., Kowdley, K.V. Am. J. Gastroenterol. (2002) [Pubmed]
WikiGenes - Universities